Henning Kelbæk

Showing 1-20 of 27 articles

Author Henning Kelbæk

Coronary interventions

Five-year clinical outcomes for the Resolute zotarolimus-eluting stent in total coronary occlusions

Kelbæk H, Yeh R, Engstrøm T, Neumann F-J, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S

November 20, 2019 | 10.4244/EIJ-D-19-00866

Author Muhammad Sabbah

Coronary interventions

Fractional Flow Reserve Guided PCI in Patients With and Without Left Ventricular Hypertrophy: a DANAMI-3-PRIMULTI Sub-study

Sabbah M, Nepper-Christensen L, Lønborg J, Helqvist S, Køber L, Høfsten D, Ahtarovski K, Goransson C, Kyhl K, Schoos M, Vejlstrup N, Kelbæk H, Engstrøm T

November 20, 2019 | 10.4244/EIJ-D-19-00577

Author Ole De Backer

Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy

De Backer O, Lønborg J, Helqvist S, Warnøe J, Kløvgaard L, Holmvang L, Pedersen F, Tilsted H, Raungaard B, Jørgensen E, Køber L, Høfsten D, Kelbæk H, Engstrøm T

June 20, 2019 | 10.4244/EIJ-D-18-00766

Author Lars Kjoller-Hansen

Coronary interventions

Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments

Kjoller-Hansen L, Bligaard N, Kelbæk H, Christiansen EH, Thuesen L, Hansen PR, Engstrøm T, Junker A, Abildgaard U, Flensted Lassen J, Jensen JS, Jeppesen JL, Galloe A

September 20, 2018 | 10.4244/EIJ-D-18-00396

Author Lars Nepper-Christensen

STEMI

Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy

Nepper-Christensen L, Lønborg J, Hofsten D, Ahtarovski K, Kyhl K, Goransson C, Køber L, Helqvist S, Pedersen F, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T

August 24, 2018 | 10.4244/EIJ-D-17-00857

Author Henning Kelbæk

Coronary interventions

To defer, or not to defer, that is the question

Kelbæk H, Hofsten D, Engstrøm T

July 20, 2017 | 10.4244/EIJV13I4A58

Author Golnaz Sadjadieh

Coronary interventions

Bleeding episodes in “complete, staged” versus “culprit only” revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy

Sadjadieh G, Engstrøm T, Helqvist S, Hofsten D, Køber L, Pedersen F, Clemmensen P, Jørgensen E, Saunamäki K, Tilsted H, Kelbæk H, Holmvang L

November 20, 2016 | 10.4244/EIJV12I10A203

Author Homa Waziri

Coronary interventions

Acute myocardial infarction and lesion location in the left circumflex artery: importance of coronary artery dominance

Waziri H, Jørgensen E, Kelbæk H, Fosbøl E, Pedersen F, Mogensen U, Gerds T, Køber L, Wachtell K

July 20, 2016 | 10.4244/EIJY15M09_04

Author Kasper Kyhl

Coronary interventions

A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction

Kyhl K, Lønborg J, Vejlstrup N, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Bøtker H, Clemmensen P, Køber L, Treiman M, Engstrøm T

July 20, 2016 | 10.4244/EIJV12I4A78

Author Ole De Backer

Coronary interventions

Long-term outcome of FFR-guided PCI for stable coronary artery disease in daily clinical practice: a propensity score-matched landmark analysis

De Backer O, Biasco L, Lønborg J, Pedersen F, Holmvang L, Kelbæk H, Arnous S, Saunamäki K, Helqvist S, Kastrup J, Jørgensen E, Engstrøm T

February 12, 2016 | 10.4244/EIJV11I11A247

Author Henning Kelbæk

Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions

Kelbæk H, Holmvang L, Richardt G, Eberli F, Stella P, Buszman P, Neumann F-J, Serruys P, Windecker S, Widimsky P, Belardi J, Silber S

October 20, 2015 | 10.4244/EIJY14M07_14

Author Mikkel Malby Schoos

Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to “mega centre” for patients with ST-segment elevation myocardial infarction

Schoos M, Pedersen F, Holmvang L, Engstrøm T, Saunamäki K, Helqvist S, Kastrup J, Mehran R, Dangas G, Jørgensen E, Kelbæk H, Clemmensen P

September 22, 2015 | 10.4244/EIJY14M11_07

Author Masanori Taniwaki

Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials

Taniwaki M, Stefanini GG, Räber L, Brugaletta S, Cequier A, Heg D, Iñiguez A, Kelbæk H, Serra A, Ostojic M, Hernández-Antolín R, Baumbach A, Blochlinger S, Jüni P, Mainar V, Sabaté M, Windecker S

August 20, 2015 | 10.4244/EIJY14M07_12

Author Victoria Martin-Yuste

How should I treat subacute stent thrombosis in the context of brain haemorrhage with abciximab?

Martin-Yuste V, Alvarez-Contreras L, Sabaté M, Kelbæk H, Saunamäki K, Jørgensen E, Kočka V

February 20, 2015 | 10.4244/EIJV10I10A208

Author Jacob Lønborg

ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial infarction

Lønborg J, Kelbæk H, Engstrøm T, Helqvist S, Kløvgaard L, Holmvang L, Vejlstrup N, Jørgensen E, Saunamäki K, Dridi N, Kaltoft A, Bøtker H, Clemmensen P, Terkelsen C

August 19, 2014 | 10.4244/EIJV10I4A80

Author Maria Radu

Flow disturbances in stent-related coronary evaginations: a computational fluid-dynamic simulation study

Radu M, Pfenniger A, Räber L, de Marchi S, Obrist D, Kelbæk H, Windecker S, Serruys P, Vogel R

May 20, 2014 | 10.4244/EIJV10I1A18

Author Maria Radu

Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation

Radu M, Räber L, Heo J, Gogas B, Jørgensen E, Kelbæk H, Muramatsu T, Farooq V, Helqvist S, Garcia-Garcia H, Windecker S, Saunamäki K, Serruys P

January 20, 2014 | 10.4244/EIJV9I9A183

Author Ian T. Meredith

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Meredith I, Verheye S, Weissman N, Barragan P, Scott D, Valdés Chávarri M, West N, Kelbæk H, Whitbourn R, Walters D, Kubica J, Thuesen L, Masotti M, Banning A, Sjogren I, Stables R, Allocco D, Dawkins K

July 26, 2013 | 10.4244/EIJV9I3A52

Author Henning Kelbæk

Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study

Kelbæk H, Engstrøm T, Ahtarovski K, Lønborg J, Vejlstrup N, Pedersen F, Holmvang L, Helqvist S, Saunamäki K, Jørgensen E, Clemmensen P, Kløvgaard L, Tilsted H, Raungaard B, Ravkilde J, Aaroe J, Eggert S, Køber L

February 22, 2013 | 10.4244/EIJV8I10A175

Author Lorenz Räber

Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques

Räber L, Heo J, Radu M, Garcia-Garcia H, Stefanini GG, Moschovitis A, Dijkstra J, Kelbæk H, Windecker S, Serruys P

May 15, 2012 | 10.4244/EIJV8I1A16

1
2

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

New this week: A Dose-response Meta Analysis, stroke after MitraClip and more

December 10, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: EXTREME Study, Stent Optimization and more

December 3, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke